Last reviewed · How we verify
SHR-2017 injection
At a glance
| Generic name | SHR-2017 injection |
|---|---|
| Sponsor | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors (PHASE2)
- PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases (PHASE1)
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |